Tranexamic acid arrived in skincare sideways. It is a medication used to slow heavy bleeding, and in the 1970s Japanese clinicians using it for other reasons noticed that patients who also had melasma saw their pigmentation settle. That observation became a body of dermatology research, and the ingredient eventually appeared in serums.
It is worth knowing that history, because it explains both why tranexamic acid behaves differently from the usual brightening actives and why the strongest evidence for it involves a form most people cannot buy.
The pathway it works on
Most brightening ingredients target tyrosinase, the enzyme melanocytes use to build melanin. Alpha arbutin, kojic acid and vitamin C all do some version of that, as how melanin production works sets out.
Tranexamic acid works further upstream. It blocks plasmin, an enzyme involved in inflammation and in the breakdown of blood clots. Plasmin turns out to be one of the signals that tells melanocytes to get busy, particularly after ultraviolet exposure, and it is also involved in the small blood vessel activity that sits underneath melasma patches. Blocking it quietens the instruction rather than the machinery carrying it out.
That difference matters for one condition in particular. Melasma is driven by hormones, heat and light rather than by a single injury, and it has a vascular component that purely tyrosinase-focused actives do not touch. This is why tranexamic acid earned its reputation there and not for general dark spots.
Topical, oral and injected
Three routes exist and they are not interchangeable.
Oral tranexamic acid, at low doses over months, has the strongest published evidence in melasma. It is also a medication with a clotting mechanism, which means it is not appropriate for anyone with a history of clots, certain cardiac conditions, smoking combined with hormonal contraception, or pregnancy. It belongs to a dermatologist who knows your history, and it is prescribed rather than bought.
Injected or micro-needled tranexamic acid is a clinic procedure with its own evidence base and its own risks in deeper skin tones, where any needling can leave pigment behind.
Topical tranexamic acid is what appears in serums, usually somewhere between two and five per cent, sometimes as a derivative. The molecule is water soluble and not especially good at getting through the skin barrier, which is the honest catch: the results in studies of topical use are real but modest compared with the oral route, and they take months rather than weeks.
Who it suits
It is a reasonable choice for melasma that has been correctly identified, for pigmentation that flares with heat and sun rather than with a specific injury, and for skin that has not tolerated stronger actives. It is generally well tolerated, with less stinging than vitamin C and less irritation than acids, which is part of its appeal.
It layers without drama alongside niacinamide, sunscreen and moisturisers, and the ingredient pairing checker covers the combinations Cham has written about.
It is not the right first move for post-inflammatory marks from acne, which are a different problem with a different answer in acne marks and acne scars. It is also not a substitute for sun protection, and with melasma in particular it is close to useless without it, because the trigger is still firing.
What it will not do
It does not change baseline skin tone, and nothing sold as a cosmetic does. It does not work quickly, and any topical promising a visible change in a fortnight is describing something other than pigment. And it does not hold a result that is not protected: melasma returns with light and heat exposure regardless of what cleared it, which is the point made in melasma, and where cosmetics stop.
If pigmentation is being approached as melasma without a diagnosis, the most useful thing available is not an ingredient at all. Melasma and hyperpigmentation are different problems, and the melasma season planner covers the seasonal pattern that catches people out.
Where Cham stands
Cham makes no tranexamic acid product. The range is built on niacinamide, alpha arbutin and two forms of vitamin C, which work on the tyrosinase side of the same problem. That is a formulation choice rather than a verdict on the ingredient, and if a dermatologist has suggested tranexamic acid for melasma, that advice outranks anything here.
The one thing worth carrying away is that the oral form is where the strong evidence lives, and the oral form is a medication. It is not something to source from a marketplace listing on the strength of a serum's reputation.
